Nitrous oxide lacks the antinociceptive effect on the tail flick test in newborn rats

Anesthesia and Analgesia

Volumn 91, Issue 1, 2000, Pages 6-10

  Fujinaga, Masahiko ^a,b,c   Doone, Ryan ^a   Davies, M Frances ^a   Maze, Mervyn ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITROUS OXIDE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

EID: 0033946840     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200007000-00002     Document Type: Article

References (29)

1. Murray D, Mehta MP, Forbes R, Dull D, et al. Additive contribution of nitrous oxide to halothane MAC in infants and children. Anesth Analg 1990;70:120-4.
2. Murray DL, Mehta MP, Forbes RB. The additive contribution of nitrous oxide to isoflurane MAC in infants and children. Anesthesiology 1991;75:186-90.
3. 2O on infants and children. Anesthesiology 1992;76:354-6.
4. Lerman J, Sikich N, Kleinman S, Yentis S. The pharmacology of sevoflurane in infants and children. Anesthesiology 1994;80: 814-24.
5. Swan HD, Crawford MW, Pua HL, et al. Additive contribution of nitrous oxide to sevoflurane minimum alveolar concentration for tracheal intubation in children. Anesthesiology 1999;91: 667-71.
6. Hodges BL, Gagnon MJ, Gillespie TR, et al. Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade. J Pharmacol Exp Ther 1994;269:596-600.
7. Zuniga J, Joseph S, Knigge K. Nitrous oxide analgesia: partial antagonism by naloxone and total reversal after periaqueductal gray lesions in the rat. Eur J Pharmacol 1987;142:51-60.
8. 2 adrenergic receptors in the rat. Anesthesiology 1996;85:846-52.
9. Fang F, Guo TZ, Davies MF, Maze M. Opiate receptors in the periaqueductal gray mediate analgesic effect of nitrous oxide in rats. Eur J Pharmacol 1997;336:137-41.
10. Rajaofetra N, Poulat P, Marlier L, et al. Pre-and postnatal development of noradrenergic projections to the rat spinal cord: an immunocytochemical study. Brain Res Dev Brain Res 1992; 67:237-46.
11. Fitzgerald M, Koltzenburg M. The functional development of descending inhibitory pathways in the dorsolateral funiculus of the newborn rat spinal cord. Brain Res 1986;389:261-70.
12. Hammond DL. Inference of pain and its modulation from simple behaviors. In: Chapman CR and Loeser JD, eds. Issues in pain measurement: advances in pain research and therapy. Vol. 12. New York: Raven Press, 1989:69-91.
13. Westlund KN, Zhang D, Carlton SM, et al. Noradrenergic innervation of somatosensory thalamus and spinal cord. Prog Brain Res 1991;88:77-88.
14. Willcockson WS, Chung JM, Hori Y, Lee KH, et al. Effects of ionotophoretically released amino acids and amines on primate spinothalamic tract cells. J Neurosci 1984;4:732-40.
15. Petrovaara A, Kauppila T, Jyvasjarvi E, Kalso E. Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception. Neuroscience 1991:44;705-11.
16. West WL, Yeomans DC, Proudfit HK. The function of noradrenergic neurons in mediating antinociception induced by electrical stimulation of the locus coeruleus in two different sources of Sprague-Dawley rats. Brain Res 1993;626:127-35.
17. Peng YB, Lin Q, Willis WD. Involvement of alpha-2 adrenoceptors in the periaqueductal gray-induced inhibition of dorsal horn cell activity in rats. J Pharmacol Exp Ther 1996;278:125-35.
18. Aramant RB, Poulat P, Marlier L, et al. Postnatal development of dopamine-β-hydroxylase-immunoreactive fibers of the spinal cord of the rat. Dev Brain Res 1986;25:161-71.
19. Tive LA, Barr GA. Analgesia from the periaqueductal gray in the developing rat: focal injections of morphine or glutamate and effects of intrathecal injection of methysergide or phentolamine. Brain Res 1992;584:92-109.
20. Van Praag H, Frenk H. The development of stimulation-produced analgesia (SPA) in the rat. Brain Res Dev Brain Res 1991;64:71-6.
21. Fitzgerald M, Shaw A, MacIntosh N. Postnatal development of the cutaneous flexor reflex: comparative study of preterm infants and newborn rat pups. Dev Med Child Neurol 1988;30: 520-6.
22. Conway CM, Martinez J, Lytle LD. Maturational changes in the thermal nociceptive responses of developing rats. Dev Psychobiol 1998;33:47-60.
23. Berkowitz BA, Finck AD, Ngai SH. Nitrous oxide analgesia: reversal by naloxone and development of tolerance. J Pharmacol Exp Ther 1977;203:539-47.
24. Berkowitz BA, Finck AD, Hynes MD, Ngai SH. Tolerance to nitrous oxide analgesia in rats and mice. Anesthesiology 1979; 51:309-12.
25. Rupreht J, Dworacek B, Bonke B, et al. Tolerance to nitrous oxide decreases in volunteers. Acta Anaesthesiol Scand 1985;29: 635-8.
26. Ramsay DS, Brown AC, Woods SC. Acute tolerance to nitrous oxide in humans. Pain 1992;51:367-73.
27. Mori K, Winters WD. Neural blockade of sleep and anesthesia. Int Anesthesiol Clin 1975;13:67-108.
28. Stevens JE, Oshima E, Mori K. Effects of nitrous oxide on the epileptogenic property of enflurane in cats. Br J Anaesth 1983; 55:145-54.
29. Ngai SH, Finck AD. Prolonged exposure to nitrous oxide decreases opiate receptor density in rat brainstem. Anesthesiology 1982;57:26-30.